Biaffin

Newsletter

kinases protein kinase inhibitors signaling activators kinase substrates antibodies bioluminescence assays
Recombinant Mouse CD40 Ligand / TNFSF5 Protein, Fc Tag, 100 µg  

Recombinant Mouse CD40 Ligand / TNFSF5 Protein, Fc Tag, 100 µg

Recombinant Mouse CD40 Ligand / TNFSF5 Protein, AA Gly 115 - Leu 260, expressed from human 293 cells (HEK293), Avitag™,Fc Tag

Synonym: Recombinant, protein, CD40LG, CD154, CD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAP, gp39

More details

CDL-M526x-100

Availability: within 7 days

390,00 €

Background
CD40 ligand is also known as CD40L, CD154, TNFSF5 and T-cell antigen Gp39, is a single-pass type I I membrane protein which belongs to the TNF superfamily of molecules. CD40 ligand is expressed predominantly on activated CD4+ T lymphocytes, and also found in other types of cells, including platelets, mast cells, macrophages, basophils, NK cells, B lymphocytes, as well as non-haematopoietic cells (smooth muscle cells, endothelial cells, and epithelial cells). Although all monomeric, dimeric and trimeric forms of soluble CD40 ligand can bind to CD40, the trimeric form of soluble CD40 ligand has the most potent biological activity through oligomerization of cell surface CD40, a common feature of TNF receptor family members. CD40 ligand binds to CD40 on antigen-presenting cells (APC), which leads to many effects depending on the target cell type. In general, CD40 ligand plays the role of a costimulatory molecule and induces activation in APC in association with T cell receptor stimulation by MHC molecules on the APC. In total CD40 ligand has three binding partners: CD40, α5β1 integrin and αIIbβ3. CD40 ligand regulates B cell function by engaging CD40 on the B cell surface. A defect in this gene results in an inability to undergo immunoglobulin class switch and is associated with hyper IgM syndrome.

Source
Recombinant Mouse CD40 Ligand, Fc Tag (CDL-M526x) is expressed from human 293 cells (HEK293). It contains AA Gly 115 - Leu 260 (Accession # P27548-1).

Molecular Characterization
This protein carries a human IgG1 Fc tag at the N-terminus.
The protein has a calculated MW of 42.9 kDa. As a result of glycosylation, the protein migrates as 52 kDa under reducing (R) condition, and 90-116 kDa under non-reducing (NR) condition (SDS-PAGE).

Endotoxin
Less than 1.0 EU per μg by the LAL method.

Purity
>95% as determined by SDS-PAGE.

Formulation
Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5. Normally trehalose is added as protectant before lyophilization.

Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.

Bioactivity
Please refer to product data sheet.

Clinical and Translational Updates

(1)  "Preoperative soluble cluster of differentiation 40 ligand level is associated with outcome of pulmonary endarterectomy"
Shigeta, Tanabe, Naito et al
JTCVS Open (2021) 8, 618-629
(2)  "Commentary: The proinflammatory soluble CD40 ligand is associated with worse outcomes after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension"
Wong, Hsin
JTCVS Open (2021) 8, 631-632
(3)  "Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer"
Moutafi, Molero, Martinez Morilla et al
J Immunother Cancer (2022) 10 (8)
Showing 1-3 of 8091 papers.